Skip to main content
Top
Published in: BMC Anesthesiology 1/2017

Open Access 01-12-2017 | Research article

Randomized comparison of sevoflurane versus propofol-remifentanil on the cardioprotective effects in elderly patients with coronary heart disease

Authors: Yunlong Zhang, Wendong Lin, Sheliang Shen, Hongfa Wang, Xiaona Feng, Jiehao Sun

Published in: BMC Anesthesiology | Issue 1/2017

Login to get access

Abstract

Background

It is skeptical about cardioprotective property of sevoflurane in patients undergoing noncardiac surgery, especially in the elderly patients with coronary heart disease. We hypothesized that long duration of sevoflurane inhalation in noncardiac surgery could ameliorate myocardial damage in such patients.

Methods

This was a randomized, prospective study. One hundred twenty-one elderly patients with coronary heart disease were randomly allocated into two groups. Maintenance of anesthesia was achieved by sevoflurane inhalation (Group S) or propofol-remifentanil respectively (Group PR). Serum cardiac troponin I (cTnI) and brain natriuretic peptide (BNP) were measured before anesthesia induction (T0), 8 h (T1) and 24 h (T2) after anesthesia respectively. The perioperative cardiac output, complications and postoperative 3-month follow-up from end of surgery were recorded.

Results

Between the two groups, there were no statistical differences in the values of cTnI and BNP during the study. However, The area under the curve of cTnI values over 24 h after operation was less in Group S. Group PR had lower cardiac output and consumed more amount of phenylephrine during the study (P < 0.05).

Conclusions

Compared with the group PR, sevoflurane had no benefit in the myocardial protection for the elderly patients with CHD. However, Sevoflurane showed advantage in maintaining hemodynamic stability during the operative period.

Trial registration

Chinese Clinical Trial Registry, ChiCTR-IPR-16008871, 21 July 2016.
Literature
1.
go back to reference Alcock RF, Kouzios D, Naoum C, Hillis GS, Brieger DB. Perioperative myocardial necrosis in patients at high cardiovascular risk undergoing elective non-cardiac surgery. Heart. 2012;98:792–8.CrossRefPubMed Alcock RF, Kouzios D, Naoum C, Hillis GS, Brieger DB. Perioperative myocardial necrosis in patients at high cardiovascular risk undergoing elective non-cardiac surgery. Heart. 2012;98:792–8.CrossRefPubMed
2.
go back to reference Gao S, Yang Z, Shi R, Xu D, Li H, Xia Z, et al. Diabetes blocks the cardioprotective effects of sevoflurane postconditioning by impairing Nrf2/Brg1/HO-1 signaling. Eur J Pharmacol. 2016;779:111–21.CrossRefPubMed Gao S, Yang Z, Shi R, Xu D, Li H, Xia Z, et al. Diabetes blocks the cardioprotective effects of sevoflurane postconditioning by impairing Nrf2/Brg1/HO-1 signaling. Eur J Pharmacol. 2016;779:111–21.CrossRefPubMed
3.
go back to reference Lemoine S, Tritapepe L, Hanouz JL, Puddu PE. The mechanisms of cardio-protective effects of desflurane and sevoflurane at the time of reperfusion: anaesthetic post-conditioning potentially translatable to humans? Br J Anaesth. 2016;116:456–75.CrossRefPubMed Lemoine S, Tritapepe L, Hanouz JL, Puddu PE. The mechanisms of cardio-protective effects of desflurane and sevoflurane at the time of reperfusion: anaesthetic post-conditioning potentially translatable to humans? Br J Anaesth. 2016;116:456–75.CrossRefPubMed
4.
go back to reference Kunst G, Klein AA. Peri-operative anaesthetic myocardial preconditioning and protection-cellular mechanisms and clinical relevance in cardiac anaesthesia. Anaesthesia. 2015;70:467–82.CrossRefPubMedPubMedCentral Kunst G, Klein AA. Peri-operative anaesthetic myocardial preconditioning and protection-cellular mechanisms and clinical relevance in cardiac anaesthesia. Anaesthesia. 2015;70:467–82.CrossRefPubMedPubMedCentral
5.
go back to reference Kojima A, Kitagawa H, Omatsu-Kanbe M, Matsuura H, Nosaka S. Sevoflurane protects ventricular myocytes against oxidative stress-induced cellular Ca2+ overload and hypercontracture. Anesthesiology. 2013;119:606–20.CrossRefPubMed Kojima A, Kitagawa H, Omatsu-Kanbe M, Matsuura H, Nosaka S. Sevoflurane protects ventricular myocytes against oxidative stress-induced cellular Ca2+ overload and hypercontracture. Anesthesiology. 2013;119:606–20.CrossRefPubMed
6.
go back to reference Zhang J, Wang C, Yu S, Luo Z, Chen Y, Liu Q, et al. Sevoflurane postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signaling. Sci Rep. 2014;4:7317.CrossRefPubMedPubMedCentral Zhang J, Wang C, Yu S, Luo Z, Chen Y, Liu Q, et al. Sevoflurane postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signaling. Sci Rep. 2014;4:7317.CrossRefPubMedPubMedCentral
7.
go back to reference Bonvini JM, Beck-Schimmer B, Kuhn SJ. Late post-conditioning with sevoflurane after cardiac surgery - are surrogate markers associated with clinical outcome? PLoS One. 2015;10:e0132165.CrossRefPubMedPubMedCentral Bonvini JM, Beck-Schimmer B, Kuhn SJ. Late post-conditioning with sevoflurane after cardiac surgery - are surrogate markers associated with clinical outcome? PLoS One. 2015;10:e0132165.CrossRefPubMedPubMedCentral
8.
go back to reference Landoni G, Fochi O, Bignami E, Calabr MG, Darpa MC, Moizo E, et al. Cardiac protection by volatile anesthetics in non-cardiac surgery? A meta-analysis of randomized controlled studies on clinically relevant endpoints. HSR Proc Intensive Care Cardiovasc Anesth. 2009;1:34–43.PubMedPubMedCentral Landoni G, Fochi O, Bignami E, Calabr MG, Darpa MC, Moizo E, et al. Cardiac protection by volatile anesthetics in non-cardiac surgery? A meta-analysis of randomized controlled studies on clinically relevant endpoints. HSR Proc Intensive Care Cardiovasc Anesth. 2009;1:34–43.PubMedPubMedCentral
9.
go back to reference Li H, Zhou C, Chen D, Fang N, Yao Y, Li L. Failure to protect against myocardial ischemia-reperfusion injury with sevoflurane postcondition in old rats in vivo. Acta Anaesthesiolscand. 2013;57:1024–31.CrossRef Li H, Zhou C, Chen D, Fang N, Yao Y, Li L. Failure to protect against myocardial ischemia-reperfusion injury with sevoflurane postcondition in old rats in vivo. Acta Anaesthesiolscand. 2013;57:1024–31.CrossRef
10.
go back to reference Tambyraja AL, Dawson ARW, Murie JA, Chalmers RT. Cardiac troponin I predicts outcome after ruptured abdominal aortic aneurysm repair. Br J Surg. 2005;92:824–7.CrossRefPubMed Tambyraja AL, Dawson ARW, Murie JA, Chalmers RT. Cardiac troponin I predicts outcome after ruptured abdominal aortic aneurysm repair. Br J Surg. 2005;92:824–7.CrossRefPubMed
11.
go back to reference Ali ZA, Callaghan CJ, Ali AA, Sherkh AY, Akhtar A, Pavlovic A, et al. Perioperative myocardial injury after elective open abdominal aortic aneurysm repair predicts outcome. Eur J Vasc Endovasc Surg. 2008;35:413–9.CrossRefPubMed Ali ZA, Callaghan CJ, Ali AA, Sherkh AY, Akhtar A, Pavlovic A, et al. Perioperative myocardial injury after elective open abdominal aortic aneurysm repair predicts outcome. Eur J Vasc Endovasc Surg. 2008;35:413–9.CrossRefPubMed
12.
go back to reference Uhlig C, Bluth T, Schwarz K, Deckert S, Heinrich L, De Hert S, et al. Effects of volatile anesthetics on mortality and postoperative pulmonary and other complications in patients undergoing surgery: a systematic review and meta-analysis. Anesthesiology. 2016;124:1230–45.CrossRefPubMed Uhlig C, Bluth T, Schwarz K, Deckert S, Heinrich L, De Hert S, et al. Effects of volatile anesthetics on mortality and postoperative pulmonary and other complications in patients undergoing surgery: a systematic review and meta-analysis. Anesthesiology. 2016;124:1230–45.CrossRefPubMed
13.
go back to reference De Hert S, Vlasselaers D, Barbe R, Ory JP, Dekegel D, Donnadonni R, et al. A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery. Anaesthesia. 2009;64:953–60.CrossRefPubMed De Hert S, Vlasselaers D, Barbe R, Ory JP, Dekegel D, Donnadonni R, et al. A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery. Anaesthesia. 2009;64:953–60.CrossRefPubMed
14.
go back to reference Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Nucl Cardiol. 2015;130:2373–405. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Nucl Cardiol. 2015;130:2373–405.
15.
go back to reference Lurati Buse GA, Schumacher P, Seeberger E, Studer W, Schuman RM, Fassl J, et al. Randomized comparison of sevoflurane versus propofol to reduce perioperative myocardial ischemia in patients undergoing noncardiac surgery. Circulation. 2012;126:2696–704.CrossRefPubMed Lurati Buse GA, Schumacher P, Seeberger E, Studer W, Schuman RM, Fassl J, et al. Randomized comparison of sevoflurane versus propofol to reduce perioperative myocardial ischemia in patients undergoing noncardiac surgery. Circulation. 2012;126:2696–704.CrossRefPubMed
16.
go back to reference Lindholm EE, Aune E, Norén CB, Seljeflot I, Hayeset T, Otterstad JE, et al. The anesthesia in abdominal aortic surgery (ABSENT) study: a prospective, randomized, controlled trial comparing troponin T release with fentanyl-sevoflurane and propofol-remifentanil anesthesia in major vascular surgery. Anesthesiology. 2013;119:802–12.CrossRefPubMed Lindholm EE, Aune E, Norén CB, Seljeflot I, Hayeset T, Otterstad JE, et al. The anesthesia in abdominal aortic surgery (ABSENT) study: a prospective, randomized, controlled trial comparing troponin T release with fentanyl-sevoflurane and propofol-remifentanil anesthesia in major vascular surgery. Anesthesiology. 2013;119:802–12.CrossRefPubMed
17.
go back to reference Lurati Buse GA, Schumacher P, Seeberger E, Studer W, Schuman RM, Fassl J, et al. Response to letters regarding article, “randomized comparison of Sevoflurane versus Propofol to reduce Perioperative myocardial ischemia in patients undergoing noncardiac surgery”. Circulation. 2013;127:878–9.CrossRef Lurati Buse GA, Schumacher P, Seeberger E, Studer W, Schuman RM, Fassl J, et al. Response to letters regarding article, “randomized comparison of Sevoflurane versus Propofol to reduce Perioperative myocardial ischemia in patients undergoing noncardiac surgery”. Circulation. 2013;127:878–9.CrossRef
18.
go back to reference Xu Y, Ma LL, Zhou C, Zhang FJ, Kong FJ, Wang WN, et al. Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection. PLoS One. 2013;8:e76652.CrossRefPubMedPubMedCentral Xu Y, Ma LL, Zhou C, Zhang FJ, Kong FJ, Wang WN, et al. Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection. PLoS One. 2013;8:e76652.CrossRefPubMedPubMedCentral
19.
go back to reference Nakao S, Hatano K, Sumi C, Masuzawa M, Sakamoto S, Ikeda S, et al. Sevoflurane causes greater QTc interval prolongation in elderly patients than in younger patients. Anesth Analg. 2010;110:775–9.CrossRefPubMed Nakao S, Hatano K, Sumi C, Masuzawa M, Sakamoto S, Ikeda S, et al. Sevoflurane causes greater QTc interval prolongation in elderly patients than in younger patients. Anesth Analg. 2010;110:775–9.CrossRefPubMed
20.
go back to reference Levine B, Cox D, Jufer-Phipps RA, Li L, Jacobs A, Fowler D. A fatality from sevoflurane abuse. J Anal Toxicol. 2007;31:534–6.CrossRefPubMed Levine B, Cox D, Jufer-Phipps RA, Li L, Jacobs A, Fowler D. A fatality from sevoflurane abuse. J Anal Toxicol. 2007;31:534–6.CrossRefPubMed
21.
go back to reference Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119:507–15.CrossRefPubMed Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119:507–15.CrossRefPubMed
22.
go back to reference Hallqvist L, Mårtensson J, Granath F, Sahlén A, Bell M. Intraoperative hypotension is associated with myocardial damage in noncardiac surgery. Eur J Anaesthesiol. 2016;33:450–6.CrossRefPubMed Hallqvist L, Mårtensson J, Granath F, Sahlén A, Bell M. Intraoperative hypotension is associated with myocardial damage in noncardiac surgery. Eur J Anaesthesiol. 2016;33:450–6.CrossRefPubMed
23.
go back to reference Wu AH, Lu QA, Todd J, Moecks J, Wians F. Short- and long duration biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem. 2009;55:55–8. Wu AH, Lu QA, Todd J, Moecks J, Wians F. Short- and long duration biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem. 2009;55:55–8.
24.
go back to reference Sokhanvar S, Shekhi M, Mazlomzadeh S, Golmohammadi Z. The relationship between serum NT- pro-BNP levels and prognosis in patients with systolic heart failure. J Cardiovasc Thorac Res. 2011;3:57–61.PubMedPubMedCentral Sokhanvar S, Shekhi M, Mazlomzadeh S, Golmohammadi Z. The relationship between serum NT- pro-BNP levels and prognosis in patients with systolic heart failure. J Cardiovasc Thorac Res. 2011;3:57–61.PubMedPubMedCentral
25.
go back to reference Jin YC, Kim W, Ha YM, Shin IW, Sohn JT, Kim HJ, et al. Propofol limits rat myocardial ischemia and reperfusion injury with an associated reduction in apoptotic cell death in vivo. Vasc Pharmacol. 2009;50:71–7.CrossRef Jin YC, Kim W, Ha YM, Shin IW, Sohn JT, Kim HJ, et al. Propofol limits rat myocardial ischemia and reperfusion injury with an associated reduction in apoptotic cell death in vivo. Vasc Pharmacol. 2009;50:71–7.CrossRef
26.
go back to reference Hou J, Wang H, Li X, Zhu Y. Remifentanil functions in the adaptive protection of cardiac function following ischemia. Exp Ther Med. 2017;13:1514–20.PubMedPubMedCentral Hou J, Wang H, Li X, Zhu Y. Remifentanil functions in the adaptive protection of cardiac function following ischemia. Exp Ther Med. 2017;13:1514–20.PubMedPubMedCentral
27.
go back to reference Obal D, Preckel B, Scharbatke H, Müllenheim J, Höterkes F, Thämer V, et al. One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo. Br J Anaesth. 2001;87:905–11.CrossRefPubMed Obal D, Preckel B, Scharbatke H, Müllenheim J, Höterkes F, Thämer V, et al. One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo. Br J Anaesth. 2001;87:905–11.CrossRefPubMed
Metadata
Title
Randomized comparison of sevoflurane versus propofol-remifentanil on the cardioprotective effects in elderly patients with coronary heart disease
Authors
Yunlong Zhang
Wendong Lin
Sheliang Shen
Hongfa Wang
Xiaona Feng
Jiehao Sun
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Anesthesiology / Issue 1/2017
Electronic ISSN: 1471-2253
DOI
https://doi.org/10.1186/s12871-017-0397-0

Other articles of this Issue 1/2017

BMC Anesthesiology 1/2017 Go to the issue